JP2013516619A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013516619A5 JP2013516619A5 JP2012547511A JP2012547511A JP2013516619A5 JP 2013516619 A5 JP2013516619 A5 JP 2013516619A5 JP 2012547511 A JP2012547511 A JP 2012547511A JP 2012547511 A JP2012547511 A JP 2012547511A JP 2013516619 A5 JP2013516619 A5 JP 2013516619A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- fatal
- subject
- cardiovascular event
- nidogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000090 biomarker Substances 0.000 claims description 19
- 230000007211 cardiovascular event Effects 0.000 claims description 11
- 102000012192 Cystatin C Human genes 0.000 claims description 8
- 108010061642 Cystatin C Proteins 0.000 claims description 8
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 8
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 8
- 102100037371 Nidogen-2 Human genes 0.000 claims description 8
- 101710091705 Nidogen-2 Proteins 0.000 claims description 8
- 102000013566 Plasminogen Human genes 0.000 claims description 8
- 108010051456 Plasminogen Proteins 0.000 claims description 8
- 102100035140 Vitronectin Human genes 0.000 claims description 8
- 108010031318 Vitronectin Proteins 0.000 claims description 8
- 102000003801 alpha-2-Antiplasmin Human genes 0.000 claims description 8
- 108090000183 alpha-2-Antiplasmin Proteins 0.000 claims description 8
- 210000001808 exosome Anatomy 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 208000032109 Transient ischaemic attack Diseases 0.000 claims description 4
- 208000002223 abdominal aortic aneurysm Diseases 0.000 claims description 4
- 208000007474 aortic aneurysm Diseases 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 201000010875 transient cerebral ischemia Diseases 0.000 claims description 4
- 230000002792 vascular Effects 0.000 claims description 4
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims description 2
- 206010007556 Cardiac failure acute Diseases 0.000 claims description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
- 206010025538 Malignant ascites Diseases 0.000 claims description 2
- 206010042434 Sudden death Diseases 0.000 claims description 2
- 210000004381 amniotic fluid Anatomy 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 239000010839 body fluid Substances 0.000 claims description 2
- 210000001715 carotid artery Anatomy 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 208000029078 coronary artery disease Diseases 0.000 claims description 2
- 210000004351 coronary vessel Anatomy 0.000 claims description 2
- 210000001105 femoral artery Anatomy 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 210000004251 human milk Anatomy 0.000 claims description 2
- 235000020256 human milk Nutrition 0.000 claims description 2
- 238000002350 laparotomy Methods 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 238000004393 prognosis Methods 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 210000001179 synovial fluid Anatomy 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 206010007687 Carotid artery stenosis Diseases 0.000 claims 1
- 201000000057 Coronary Stenosis Diseases 0.000 claims 1
- 206010011089 Coronary artery stenosis Diseases 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 208000006170 carotid stenosis Diseases 0.000 claims 1
- 208000030613 peripheral artery disease Diseases 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 206010051113 Arterial restenosis Diseases 0.000 description 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10150340.7 | 2010-01-08 | ||
| EP10150340 | 2010-01-08 | ||
| PCT/EP2011/050171 WO2011083145A1 (en) | 2010-01-08 | 2011-01-07 | Determination of exosomel biomarkers for predicting cardiovascular events |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013516619A JP2013516619A (ja) | 2013-05-13 |
| JP2013516619A5 true JP2013516619A5 (https=) | 2014-02-27 |
| JP5732474B2 JP5732474B2 (ja) | 2015-06-10 |
Family
ID=43533349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012547511A Expired - Fee Related JP5732474B2 (ja) | 2010-01-08 | 2011-01-07 | 心血管系イベントを予測するためのエキソソームバイオマーカーの決定 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120309041A1 (https=) |
| EP (1) | EP2521918B1 (https=) |
| JP (1) | JP5732474B2 (https=) |
| CN (1) | CN102812362B (https=) |
| AU (1) | AU2011204625B2 (https=) |
| CA (1) | CA2785592A1 (https=) |
| DK (1) | DK2521918T3 (https=) |
| SG (1) | SG181963A1 (https=) |
| WO (1) | WO2011083145A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6184410B2 (ja) * | 2011-09-06 | 2017-08-23 | トランスレーショナル サイエンシィズ インコーポレイテッド | Ｓｅｒｐｉｎｆ２結合分子および使用方法 |
| TWI420106B (zh) * | 2011-12-01 | 2013-12-21 | Univ Kaohsiung Medical | Soluble CD14 as a biomarker for detection of coronary artery disease |
| WO2013120995A1 (en) | 2012-02-17 | 2013-08-22 | Cavadis B.V. | Exosomal biomarker for cardiovascular events in females |
| CN103376313A (zh) * | 2012-04-12 | 2013-10-30 | 梁春 | 一种基于血清外来体检测急性冠脉综合征的液相芯片试剂盒及其制备方法 |
| WO2014059336A1 (en) | 2012-10-12 | 2014-04-17 | University Of Notre Dame Du Lac | Exosomes and diagnostic biomarkers |
| ES2672255T3 (es) * | 2012-12-04 | 2018-06-13 | F. Hoffmann-La Roche Ag | Biomarcadores en la selección de tratamiento para la insuficiencia cardíaca |
| CN105209881B (zh) | 2013-03-13 | 2021-01-22 | 迈阿密大学 | 从细胞培养上清液和生物流体分离并纯化微泡的方法 |
| US12558316B2 (en) | 2013-03-13 | 2026-02-24 | University Of Miami | Methods and compositions for the treatment of epidermolysis bullosa |
| WO2015060446A1 (ja) | 2013-10-25 | 2015-04-30 | 凸版印刷株式会社 | 膜小胞回収デバイス、膜小胞回収方法、及び膜小胞分析方法 |
| SG11201700557RA (en) | 2014-07-24 | 2017-02-27 | Toppan Printing Co Ltd | Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells |
| ES2792227T3 (es) | 2014-09-26 | 2020-11-10 | Somalogic Inc | Predicción de evento de riesgo cardiovascular y usos de la misma |
| WO2016140388A1 (ko) * | 2015-03-05 | 2016-09-09 | 경북대학교 산학협력단 | 엑소좀 또는 이의 단백질을 포함하는 장기 독성 진단용 바이오마커 조성물 및 이를 이용한 진단 방법 |
| EP3387444B1 (en) * | 2015-12-08 | 2023-07-05 | UMC Utrecht Holding B.V. | Extracellular vesicle markers for stable angina and unstable angina |
| WO2020004436A1 (ja) * | 2018-06-27 | 2020-01-02 | 日立化成ダイアグノスティックス・システムズ株式会社 | 試料中のエクソソームの破壊方法及び破壊用試薬 |
| CN109055489A (zh) * | 2018-08-25 | 2018-12-21 | 上海浦美医学科技有限公司 | 一种基于细胞外囊泡dna检测egfr-tki敏感突变的方法 |
| CN113970640B (zh) * | 2020-07-24 | 2022-07-08 | 首都医科大学附属北京天坛医院 | 用于ich预后评估的生物标记物及其应用 |
| CN114150057B (zh) * | 2021-12-21 | 2024-04-26 | 贾龙飞 | 一种诊断阿尔茨海默病的外泌体蛋白及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3704500A (en) * | 1999-02-19 | 2001-01-22 | University Of Iowa Research Foundation, The | Diagnostics and therapeutics for arterial wall disruptive disorders |
| AU4279900A (en) * | 1999-04-28 | 2000-11-10 | Cardiogenics Inc. | Method for determining plasminogen activator inhibitor |
| US7972802B2 (en) * | 2005-10-31 | 2011-07-05 | University Of Washington | Lipoprotein-associated markers for cardiovascular disease |
| CN101371144A (zh) * | 2006-01-25 | 2009-02-18 | 霍夫曼-拉罗奇有限公司 | 抗肌钙蛋白抗体和心血管风险 |
| EP1996949A4 (en) * | 2006-03-11 | 2010-01-20 | Univ Leland Stanford Junior | BETA-2 MICROGLOBULIN AS A BIOMARKER FOR PERIPHERAL ARTERY DISEASE |
| DE102006050497A1 (de) * | 2006-10-26 | 2008-04-30 | Brahms Aktiengesellschaft | Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II |
| DE102006058266A1 (de) * | 2006-12-08 | 2008-06-12 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Herzinsuffizienz mittels Neurophysin |
| DE102006060112A1 (de) * | 2006-12-20 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM |
| WO2009019215A1 (en) * | 2007-08-03 | 2009-02-12 | Dkfz Deutsches Krebsforschungszentrum | Method for prenatal diagnosis using exosomes and cd24 as a marker |
| CN101377492B (zh) * | 2007-08-29 | 2014-04-23 | 北京九强生物技术股份有限公司 | 胱抑素c测定试剂盒 |
| KR100970651B1 (ko) * | 2007-11-01 | 2010-07-15 | 남명진 | 난소암 진단용 키트 |
| GB2463401B (en) * | 2008-11-12 | 2014-01-29 | Caris Life Sciences Luxembourg Holdings S A R L | Characterizing prostate disorders by analysis of microvesicles |
-
2011
- 2011-01-07 CN CN201180005605.4A patent/CN102812362B/zh not_active Expired - Fee Related
- 2011-01-07 WO PCT/EP2011/050171 patent/WO2011083145A1/en not_active Ceased
- 2011-01-07 EP EP11700025.7A patent/EP2521918B1/en not_active Not-in-force
- 2011-01-07 CA CA2785592A patent/CA2785592A1/en not_active Abandoned
- 2011-01-07 SG SG2012047627A patent/SG181963A1/en unknown
- 2011-01-07 JP JP2012547511A patent/JP5732474B2/ja not_active Expired - Fee Related
- 2011-01-07 US US13/516,417 patent/US20120309041A1/en not_active Abandoned
- 2011-01-07 DK DK11700025.7T patent/DK2521918T3/en active
- 2011-01-07 AU AU2011204625A patent/AU2011204625B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013516619A5 (https=) | ||
| Zhou et al. | Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis | |
| Helms et al. | Performances of disseminated intravascular coagulation scoring systems in septic shock patients | |
| Dos Santos et al. | Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions | |
| CN102099470B (zh) | 用于诊断动脉硬化的多肽标记、用该标记等检测动脉硬化的方法以及用于诊断动脉硬化的试剂盒 | |
| MX2014002146A (es) | Métodos y composiciones para diagnóstico y pronóstico de lesión renal e insuficiencia renal. | |
| Chagan-Yasutan et al. | Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities | |
| Ozturk et al. | Pentraxin 3 is a predictor for fibrosis and arterial stiffness in patients with nonalcoholic fatty liver disease | |
| Shao et al. | Association between plasma fibrinogen levels and mortality in acute‐on‐chronic hepatitis B liver failure | |
| WO2012110253A3 (en) | Exosomal biomarkers for predicting cardiovascular events | |
| JP2014525593A (ja) | 心臓血管リスクを予測するための診断分析 | |
| US11193943B2 (en) | Endothelial cell derived exosomes and uses thereof | |
| Franz et al. | Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy | |
| Aispuru et al. | Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure | |
| Salman et al. | Prognostic significance and biologic associations of senescence‐associated secretory phenotype biomarkers in heart failure | |
| Biasiolo et al. | Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study | |
| WO2015140231A1 (en) | Soluble axl receptor tyrosine kinase in the diagnosis of cancer | |
| JP2012531605A (ja) | 心血管死亡率リスクを予測するための方法 | |
| Cui et al. | The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B | |
| JP2014518626A (ja) | 被験者が慢性腎疾患を有する、または発症するリスクがあるかどうかを決定するための方法 | |
| El Bokl et al. | Procoagulant versus anticoagulant factors in cirrhotic patients | |
| Agrawal et al. | Higher circulating natural killer cells and lower lactate levels at admission predict spontaneous survival in non-acetaminophen induced acute liver failure | |
| Blanco‐Colio et al. | Vascular proteomics and the discovery process of clinical biomarkers: the case of TWEAK | |
| JP2013522618A5 (https=) | ||
| Garcia-Tsao | Natural history of cirrhosis |